1.
Lalani A-KA, Kapoor A, Basappa NS, Bhindi B, Bjarnason GA, Bosse D, Breau RH, Canil CM, Cardenas LM, Castonguay V, Chavez-Munoz C, Chu W, Dudani S, Graham J, Heng DY, Kollmannsberger C, Lattouf J-B, Morgan S, Reaume MN, Richard PO, Swaminath A, Tanguay S, Wood LA, Lavallée LT. Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement . CUAJ [Internet]. 2023 Apr. 25 [cited 2024 Apr. 25];17(5):E154-63. Available from: https://cuaj.ca/index.php/journal/article/view/8381